ArticleBMC pharmacology & toxicology2013

Active post-marketing surveillance of the intralesional administration of human recombinant epidermal growth factor in diabetic foot ulcers.

Isis B Yera-Alos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.